Skip to main content

bulevirtide

bulevirtide: 3 clinical trials tracked.

bulevirtide evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about bulevirtide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 2 study sponsors
Clinical Trials (3)

A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)

NCT07454837·Phase 2/Phase 3·MIRM
Recruiting

Primary endpoint: Proportion of participants with undetectable HDV RNA (<LLOQ Target not detected [TND])

InterventionalRandomizedopen120 targetStarted 2026-02Completion 2029-0341 sites · Austria, Czechia, France, Germany…Mirum Pharmaceuticals, Inc.

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

NCT07200908·Phase 3·MIRM
Recruiting

Primary endpoint: Percentage of participants with a composite endpoint of virologic response and ALT normalization

InterventionalRandomizedopen172 targetStarted 2025-08Completion 2029-0950 sites · Austria, Czechia, France, Germany…Mirum Pharmaceuticals, Inc.

A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide (ECLIPSE 2)

NCT07128550·Phase 3·VIR
Active, not recruiting

Primary endpoint: HDV RNA < Lower Limit of Quantification (LLOQ), Target not detected (TND) at Week 24

InterventionalRandomizedopen150 targetStarted 2025-07Completion 2031-0738 sites · Austria, France, Germany, Italy…Vir Biotechnology, Inc.